Home Recalls D-0490-2023
Class II · Moderate risk Terminated Initiated Mar 20, 2023 (3 years ago)
Aripiprazole 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
cGMP Deviations
What was recalled
Aripiprazole 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2921-03
Recalling firm RemedyRepack Inc.
NDC code 70518-2921-03
Origin PA, United States
Initiated by Voluntary: Firm initiated
FDA recall number D-0490-2023
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Class II · Moderate risk Ongoing May 27, 2026
Reason Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as Aripiprazole Tablets USP 30 mg.
Class II · Moderate risk Ongoing Aug 28, 2025
Reason Superpotent drug
Class III · Low risk Ongoing Apr 9, 2024
Reason Cross Contamination with Other Products
Class III · Low risk Ongoing Apr 9, 2024
Reason Cross Contamination with Other Products
Class III · Low risk Ongoing Apr 9, 2024
Reason Cross Contamination with Other Products